Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Molecular Systems Biology|December 10, 2025
Single cell transcriptional perturbome in pluripotent stem cell modelsElisa Balmas, Maria L Ratto, Kirsten E Snijders, et al.
Cellular and Molecular Life Sciences : CMLS|December 30, 2025
Inhibition of HuR/ELAVL-1 attenuates fibrotic progression in Mdx mice with dilated cardiomyopathyAndrea Farini, Monica Molinaro, Debora Mostosi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 12, 2025
Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life studyGovoni Marco, Soncini Arianna, Cuda Domenico, et al.
Plos Pathogens|February 13, 2015
Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cellsAnnasara Lenman, A Manuel Liaci, Yan Liu, et al.
Nature Communications|May 22, 2026
Structural basis of signal peptide recognition by the signal peptidase complexA Manuel Liaci, Dimitrios Vismpas, Lisbeth R Kjølbye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2018
Polysialic acid is a cellular receptor for human adenovirus 52Annasara Lenman, A Manuel Liaci, Yan Liu, et al.
Brain Injury|February 15, 2021
Clinical course of SARS-CoV-2 infection in patients with severe acquired brain injury and a disorder of consciousness: an observational studyAntonio Caronni, Emanuele Liaci, Anna Bianchi, et al.
Prostate International|January 24, 2020
Adverse pathology after radical prostatectomy: the prognostic role of cumulative cancer length >6-mm threshold in prostate cancer-positive biopsiesSimone Morselli, Arcangelo Sebastianelli, Riccardo Campi, et al.
Andrology|December 4, 2020
SECRET® - SExual Chronicle REcording Table: Validation and reliabilityClaudia Zaccaro, Francesco Lotti, Simone Morselli, et al.
Minerva Urology and Nephrology|November 17, 2020
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndromeArcangelo Sebastianelli, Simone Morselli, Pietro Spatafora, et al.
Pageof 6